Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$205,930
New position
Shares Held
1,314
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,305
of 1,603 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SFMG, LLC holds $17,137,338 across 10 Drug Manufacturers - General names. NVS ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
121,108 | $5,805,917 | |
| 2 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 3 | JNJ |
Johnson & Johnson
|
14,871 | $3,776,787 | |
| 4 | ABBV |
AbbVie Inc.
|
5,732 | $1,442,400 | |
| 5 | AMGN |
Amgen Inc
|
1,884 | $682,234 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,704 | $347,464 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,723 | $272,139 | |
| 8 | AZN |
Astrazeneca PLC
|
1,394 | $264,330 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $205,930 | 1,314 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||